You are here: Industry Insights > Vaccine

News List

Pfizer Says Its COVID Vaccine Provides Full Protection to Adolescents Drugs
November 23, 2021
Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants.
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time prnasia
November 22, 2021
At 3 a.m. on November 19, the first batch of more than 4 million doses of adenovirus vector COVID-19 vaccines produced by Shenzhen Kangtai Biological Products Co., Ltd. will depart from...
Cell-free protein synthesis could enable decentralised conjugate vaccine production EuropeanPharmaceuticalReview
November 22, 2021
According to the developers, iVAX – a modular technology for in vitro conjugate vaccine expression – is portable and could overcome the challenges of ensuring cold-chain supply of conjugate vaccine products...
Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose PharmaTimes.
November 19, 2021
Following a review of evidence by the Joint Committee on Vaccination and Immunisation (JCVI), the UK Health Security Agency (UKHSA) has published new clinical guidance on vaccinations for 12 to 17 year olds.
Less Than One Year After Approval, Two Billion Doses of AstraZeneca’s COVID-19 Vaccine Have Been Supplied Globally AmericanPharmaceuticalReview
November 19, 2021
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the last 11 months.
Europe to donate 70 million doses of Moderna’s COVID-19 vaccine EuropeanPharmaceuticalReview
November 19, 2021
Moderna has announced an agreement that enables the European Union (EU) and European Economic Area (EEA) countries to donate doses of Spikevax, previously COVID-19 Vaccine Moderna...
Philippine FDA grants EUA to Novavax’s Covid-19 vaccine Pharmaceutical-Technology
November 19, 2021
The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Novavax’s Covid-19 vaccine, NVX-CoV2373, for active immunisation of people aged 18 years and above.
India has robust manufacturing capability with sufficient skilled manpower to foster innovation ExpressPharma
November 19, 2021
Give us an overview of the major advancements, shifts and trends in healthcare and lifesciences due to the COVID-19 pandemic. How will these spur investments in the research and manufacturing of biopharmaceuticals in India?
New Data Suggests More Doctors Spending Time Addressing COVID-19 Vaccine Misinformation As Compared To Six Months Ago B3Cnewswire
November 18, 2021
Sermo’s most recent COVID-19 Real Time Barometer surveyed 3,050 physicians across 26 countries and showed that while more physicians are hearing fewer concerns from patients about the side effects of the vaccine...
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines prnewswire
November 18, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page